Navigation Links
Alchem International Opens Sales and Marketing Office in the U.S.

MINNEAPOLIS, February 1, 2012 /PRNewswire/ --

Alchem International Ltd. opens its first North American office in Minneapolis. The sales and marketing office will be spearheaded by Laurent Leduc, former Vice President of Frutarom Health, Inc. This office will cater to the rapidly growing demand in North America for GMP manufacturers of extracts and their purified derivatives for the supplement, pharmaceutical and cosmetic industries.

Alchem International Ltd. is the largest manufacturer of extracts and their purified derivatives in India. Approved by the U.S. FDA, the company has three facilities that comply with international GMP standards. Alchem manufactures herbal extracts and pure pharmaceuticals that conform to USP and other international standards. Its ingredient offerings include natural extracts such as vinpocetine, Coleus Forskolin, sennosides and quinine. Alchem prides itself on its product quality, customer satisfaction and commitment to the environment.

Born in France, Leduc began his international career at Sandoz/Novartis in Minneapolis. In 1995, he led the creation of Acatris Health. Leduc's vast experience includes the release of innovative branded ingredients and proprietary blends.

"I'm very excited about opening Alchem's first North American office and welcome the opportunity to offer to the supplement and cosmetic industries premium quality ingredients and formulations supported by science," says Leduc. "My role will be to introduce the region to Alchem and its portfolio of high-quality ingredients, and to increase service to our customers in North America."

Adds Raman Mehta, CEO of Alchem International, "Our goal is to build long-term supplier relations with manufacturers that, like Alchem, are dedicated to quality and that share our passion to help consumers live a healthy life. Alchem is improving the bioavailability of well-known dietary supplement ingredients, such as silymarin and curcumin, via proprietary technology and is developing new proprietary topical blends for the cosmetics industry."

"We are already seeing an increased demand for our vinpocetine, a new ingredient launch in 2011," continues Leduc. "Vinpocetine is used as a drug for memory enhancement in many countries, and is sold as a dietary supplement in the U.S. Alchem's pharmaceutical-grade vinpocetine is naturally-derived, and is produced in our state-of-the-art facility inspected by the U.S. FDA with zero 493s. Further, it meets European Pharmacopoeia standards."

For further information, please contact:

Laurent Leduc, COO Alchem USA Inc., Tel: +1-952-933-3822, Cell: +1-612-802-6124,

SOURCE Alchem International Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. P Summit calls for a new alchemy around phosphorus and food
2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
5. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform:
6. PAREXEL International to Present at J.P. Morgan Healthcare Conference
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. International Attendance for Networking and Education at Informex Beyond Manufacturing
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
(Date:6/27/2016)...  Global demand for enzymes is forecast to ... $7.2 billion.  This market includes enzymes used in ... production, animal feed, and other markets) and specialty ... and beverages will remain the largest market for ... products containing enzymes in developing regions.  These and ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
Breaking Biology News(10 mins):